img

Global Antiretroviral Agent Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiretroviral Agent Market Insights, Forecast to 2034

The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand. In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.
Global Antiretroviral Agent market is expected to reach to US$ 49900 million in 2024, with a positive growth of %, compared with US$ 48350 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Antiretroviral Agent industry is evaluated to reach US$ 61340 million in 2029. The CAGR will be 3.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Antiretroviral Agent market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Antiretroviral Agent market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ViiV Healthcare
Gilead Sciences
GlaxoSmithKline
Merck Sharp and Dohme
Bristol-Myers Squibb
Janssen Pharmaceuticals
Pfizer
Boehringer Ingelheim
AbbVie
Genentech
Mylan
Segment by Type
Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
HIV Integrase Strand Transfer Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Entry Inhibitors—CCR5 Co-Receptor Antagonist
Fusion Inhibitors
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Antiretroviral Agent plant distribution, commercial date of Antiretroviral Agent, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Antiretroviral Agent introduction, etc. Antiretroviral Agent Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Antiretroviral Agent
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Antiretroviral Agent Product Introduction
1.2 Market by Type
1.2.1 Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 HIV Integrase Strand Transfer Inhibitors
1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.6 Entry Inhibitors—CCR5 Co-Receptor Antagonist
1.2.7 Fusion Inhibitors
1.2.8 Others
1.3 Market by Application
1.3.1 Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Agent Sales Estimates and Forecasts 2018-2029
2.2 Global Antiretroviral Agent Revenue by Region
2.2.1 Global Antiretroviral Agent Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antiretroviral Agent Revenue by Region (2018-2024)
2.2.3 Global Antiretroviral Agent Revenue by Region (2024-2029)
2.2.4 Global Antiretroviral Agent Revenue Market Share by Region (2018-2029)
2.3 Global Antiretroviral Agent Sales Estimates and Forecasts 2018-2029
2.4 Global Antiretroviral Agent Sales by Region
2.4.1 Global Antiretroviral Agent Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antiretroviral Agent Sales by Region (2018-2024)
2.4.3 Global Antiretroviral Agent Sales by Region (2024-2029)
2.4.4 Global Antiretroviral Agent Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antiretroviral Agent Sales by Manufacturers
3.1.1 Global Antiretroviral Agent Sales by Manufacturers (2018-2024)
3.1.2 Global Antiretroviral Agent Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiretroviral Agent in 2022
3.2 Global Antiretroviral Agent Revenue by Manufacturers
3.2.1 Global Antiretroviral Agent Revenue by Manufacturers (2018-2024)
3.2.2 Global Antiretroviral Agent Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Agent Revenue in 2022
3.3 Global Key Players of Antiretroviral Agent, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antiretroviral Agent Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiretroviral Agent, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiretroviral Agent, Product Offered and Application
3.8 Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiretroviral Agent Sales by Type
4.1.1 Global Antiretroviral Agent Historical Sales by Type (2018-2024)
4.1.2 Global Antiretroviral Agent Forecasted Sales by Type (2024-2029)
4.1.3 Global Antiretroviral Agent Sales Market Share by Type (2018-2029)
4.2 Global Antiretroviral Agent Revenue by Type
4.2.1 Global Antiretroviral Agent Historical Revenue by Type (2018-2024)
4.2.2 Global Antiretroviral Agent Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antiretroviral Agent Revenue Market Share by Type (2018-2029)
4.3 Global Antiretroviral Agent Price by Type
4.3.1 Global Antiretroviral Agent Price by Type (2018-2024)
4.3.2 Global Antiretroviral Agent Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antiretroviral Agent Sales by Application
5.1.1 Global Antiretroviral Agent Historical Sales by Application (2018-2024)
5.1.2 Global Antiretroviral Agent Forecasted Sales by Application (2024-2029)
5.1.3 Global Antiretroviral Agent Sales Market Share by Application (2018-2029)
5.2 Global Antiretroviral Agent Revenue by Application
5.2.1 Global Antiretroviral Agent Historical Revenue by Application (2018-2024)
5.2.2 Global Antiretroviral Agent Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antiretroviral Agent Revenue Market Share by Application (2018-2029)
5.3 Global Antiretroviral Agent Price by Application
5.3.1 Global Antiretroviral Agent Price by Application (2018-2024)
5.3.2 Global Antiretroviral Agent Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antiretroviral Agent Market Size by Type
6.1.1 US & Canada Antiretroviral Agent Sales by Type (2018-2029)
6.1.2 US & Canada Antiretroviral Agent Revenue by Type (2018-2029)
6.2 US & Canada Antiretroviral Agent Market Size by Application
6.2.1 US & Canada Antiretroviral Agent Sales by Application (2018-2029)
6.2.2 US & Canada Antiretroviral Agent Revenue by Application (2018-2029)
6.3 US & Canada Antiretroviral Agent Market Size by Country
6.3.1 US & Canada Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antiretroviral Agent Sales by Country (2018-2029)
6.3.3 US & Canada Antiretroviral Agent Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antiretroviral Agent Market Size by Type
7.1.1 Europe Antiretroviral Agent Sales by Type (2018-2029)
7.1.2 Europe Antiretroviral Agent Revenue by Type (2018-2029)
7.2 Europe Antiretroviral Agent Market Size by Application
7.2.1 Europe Antiretroviral Agent Sales by Application (2018-2029)
7.2.2 Europe Antiretroviral Agent Revenue by Application (2018-2029)
7.3 Europe Antiretroviral Agent Market Size by Country
7.3.1 Europe Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antiretroviral Agent Sales by Country (2018-2029)
7.3.3 Europe Antiretroviral Agent Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antiretroviral Agent Market Size
8.1.1 China Antiretroviral Agent Sales (2018-2029)
8.1.2 China Antiretroviral Agent Revenue (2018-2029)
8.2 China Antiretroviral Agent Market Size by Application
8.2.1 China Antiretroviral Agent Sales by Application (2018-2029)
8.2.2 China Antiretroviral Agent Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antiretroviral Agent Market Size by Type
9.1.1 Asia Antiretroviral Agent Sales by Type (2018-2029)
9.1.2 Asia Antiretroviral Agent Revenue by Type (2018-2029)
9.2 Asia Antiretroviral Agent Market Size by Application
9.2.1 Asia Antiretroviral Agent Sales by Application (2018-2029)
9.2.2 Asia Antiretroviral Agent Revenue by Application (2018-2029)
9.3 Asia Antiretroviral Agent Sales by Region
9.3.1 Asia Antiretroviral Agent Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antiretroviral Agent Revenue by Region (2018-2029)
9.3.3 Asia Antiretroviral Agent Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiretroviral Agent Market Size by Type
10.1.1 Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antiretroviral Agent Market Size by Application
10.2.1 Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antiretroviral Agent Sales by Country
10.3.1 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Information
11.1.2 ViiV Healthcare Overview
11.1.3 ViiV Healthcare Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ViiV Healthcare Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ViiV Healthcare Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Gilead Sciences Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Information
11.4.2 Merck Sharp and Dohme Overview
11.4.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck Sharp and Dohme Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Sharp and Dohme Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bristol-Myers Squibb Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Janssen Pharmaceuticals
11.6.1 Janssen Pharmaceuticals Company Information
11.6.2 Janssen Pharmaceuticals Overview
11.6.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Janssen Pharmaceuticals Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Janssen Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pfizer Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Overview
11.8.3 Boehringer Ingelheim Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Boehringer Ingelheim Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer Ingelheim Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Information
11.9.2 AbbVie Overview
11.9.3 AbbVie Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 AbbVie Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AbbVie Recent Developments
11.10 Genentech
11.10.1 Genentech Company Information
11.10.2 Genentech Overview
11.10.3 Genentech Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Genentech Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Genentech Recent Developments
11.11 Mylan
11.11.1 Mylan Company Information
11.11.2 Mylan Overview
11.11.3 Mylan Antiretroviral Agent Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Mylan Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiretroviral Agent Industry Chain Analysis
12.2 Antiretroviral Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Agent Production Mode & Process
12.4 Antiretroviral Agent Sales and Marketing
12.4.1 Antiretroviral Agent Sales Channels
12.4.2 Antiretroviral Agent Distributors
12.5 Antiretroviral Agent Customers
13 Market Dynamics
13.1 Antiretroviral Agent Industry Trends
13.2 Antiretroviral Agent Market Drivers
13.3 Antiretroviral Agent Market Challenges
13.4 Antiretroviral Agent Market Restraints
14 Key Findings in The Global Antiretroviral Agent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Nucleoside Reverse Transcriptase Inhibitors
Table 3. Major Manufacturers of Protease Inhibitors
Table 4. Major Manufacturers of HIV Integrase Strand Transfer Inhibitors
Table 5. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 6. Major Manufacturers of Entry Inhibitors—CCR5 Co-Receptor Antagonist
Table 7. Major Manufacturers of Fusion Inhibitors
Table 8. Major Manufacturers of Others
Table 9. Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Antiretroviral Agent Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Antiretroviral Agent Revenue by Region (2018-2024) & (US$ Million)
Table 12. Global Antiretroviral Agent Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global Antiretroviral Agent Revenue Market Share by Region (2018-2024)
Table 14. Global Antiretroviral Agent Revenue Market Share by Region (2024-2029)
Table 15. Global Antiretroviral Agent Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Antiretroviral Agent Sales by Region (2018-2024) & (K Units)
Table 17. Global Antiretroviral Agent Sales by Region (2024-2029) & (K Units)
Table 18. Global Antiretroviral Agent Sales Market Share by Region (2018-2024)
Table 19. Global Antiretroviral Agent Sales Market Share by Region (2024-2029)
Table 20. Global Antiretroviral Agent Sales by Manufacturers (2018-2024) & (K Units)
Table 21. Global Antiretroviral Agent Sales Share by Manufacturers (2018-2024)
Table 22. Global Antiretroviral Agent Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 23. Global Antiretroviral Agent Revenue Share by Manufacturers (2018-2024)
Table 24. Global Key Players of Antiretroviral Agent, Industry Ranking, 2021 VS 2022 VS 2024
Table 25. Antiretroviral Agent Price by Manufacturers 2018-2024 (US$/Unit)
Table 26. Global Antiretroviral Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Antiretroviral Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Agent as of 2022)
Table 28. Global Key Manufacturers of Antiretroviral Agent, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Antiretroviral Agent, Product Offered and Application
Table 30. Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 33. Global Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 34. Global Antiretroviral Agent Sales Share by Type (2018-2024)
Table 35. Global Antiretroviral Agent Sales Share by Type (2024-2029)
Table 36. Global Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 37. Global Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global Antiretroviral Agent Revenue Share by Type (2018-2024)
Table 39. Global Antiretroviral Agent Revenue Share by Type (2024-2029)
Table 40. Antiretroviral Agent Price by Type (2018-2024) & (US$/Unit)
Table 41. Global Antiretroviral Agent Price Forecast by Type (2024-2029) & (US$/Unit)
Table 42. Global Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 43. Global Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 44. Global Antiretroviral Agent Sales Share by Application (2018-2024)
Table 45. Global Antiretroviral Agent Sales Share by Application (2024-2029)
Table 46. Global Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 47. Global Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global Antiretroviral Agent Revenue Share by Application (2018-2024)
Table 49. Global Antiretroviral Agent Revenue Share by Application (2024-2029)
Table 50. Antiretroviral Agent Price by Application (2018-2024) & (US$/Unit)
Table 51. Global Antiretroviral Agent Price Forecast by Application (2024-2029) & (US$/Unit)
Table 52. US & Canada Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 53. US & Canada Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 54. US & Canada Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 55. US & Canada Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 57. US & Canada Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 58. US & Canada Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 59. US & Canada Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada Antiretroviral Agent Revenue by Country (2018-2024) & (US$ Million)
Table 62. US & Canada Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada Antiretroviral Agent Sales by Country (2018-2024) & (K Units)
Table 64. US & Canada Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 65. Europe Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 66. Europe Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 67. Europe Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 70. Europe Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 71. Europe Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe Antiretroviral Agent Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe Antiretroviral Agent Sales by Country (2018-2024) & (K Units)
Table 77. Europe Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 78. China Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 79. China Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 80. China Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 81. China Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 82. China Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 83. China Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 84. China Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 85. China Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 87. Asia Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 88. Asia Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 89. Asia Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 91. Asia Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 92. Asia Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 93. Asia Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia Antiretroviral Agent Revenue by Region (2018-2024) & (US$ Million)
Table 96. Asia Antiretroviral Agent Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia Antiretroviral Agent Sales by Region (2018-2024) & (K Units)
Table 98. Asia Antiretroviral Agent Sales by Region (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Antiretroviral Agent Sales by Type (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Antiretroviral Agent Sales by Application (2024-2029) & (K Units)
Table 105. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antiretroviral Agent Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antiretroviral Agent Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Antiretroviral Agent Sales by Country (2024-2029) & (K Units)
Table 112. ViiV Healthcare Company Information
Table 113. ViiV Healthcare Description and Major Businesses
Table 114. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. ViiV Healthcare Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. ViiV Healthcare Recent Developments
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Description and Major Businesses
Table 119. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Gilead Sciences Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Gilead Sciences Recent Developments
Table 122. GlaxoSmithKline Company Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. GlaxoSmithKline Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Merck Sharp and Dohme Company Information
Table 128. Merck Sharp and Dohme Description and Major Businesses
Table 129. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Merck Sharp and Dohme Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Merck Sharp and Dohme Recent Developments
Table 132. Bristol-Myers Squibb Company Information
Table 133. Bristol-Myers Squibb Description and Major Businesses
Table 134. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bristol-Myers Squibb Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bristol-Myers Squibb Recent Developments
Table 137. Janssen Pharmaceuticals Company Information
Table 138. Janssen Pharmaceuticals Description and Major Businesses
Table 139. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Janssen Pharmaceuticals Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Janssen Pharmaceuticals Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Pfizer Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Boehringer Ingelheim Company Information
Table 148. Boehringer Ingelheim Description and Major Businesses
Table 149. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Boehringer Ingelheim Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Boehringer Ingelheim Recent Developments
Table 152. AbbVie Company Information
Table 153. AbbVie Description and Major Businesses
Table 154. AbbVie Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. AbbVie Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. AbbVie Recent Developments
Table 157. Genentech Company Information
Table 158. Genentech Description and Major Businesses
Table 159. Genentech Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Genentech Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Genentech Recent Developments
Table 162. Mylan Company Information
Table 163. Mylan Description and Major Businesses
Table 164. Mylan Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Mylan Antiretroviral Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Mylan Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Antiretroviral Agent Distributors List
Table 170. Antiretroviral Agent Customers List
Table 171. Antiretroviral Agent Market Trends
Table 172. Antiretroviral Agent Market Drivers
Table 173. Antiretroviral Agent Market Challenges
Table 174. Antiretroviral Agent Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Agent Product Picture
Figure 2. Global Antiretroviral Agent Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antiretroviral Agent Market Share by Type in 2022 & 2029
Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 5. Protease Inhibitors Product Picture
Figure 6. HIV Integrase Strand Transfer Inhibitors Product Picture
Figure 7. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
Figure 8. Entry Inhibitors—CCR5 Co-Receptor Antagonist Product Picture
Figure 9. Fusion Inhibitors Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antiretroviral Agent Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global Antiretroviral Agent Market Share by Application in 2022 & 2029
Figure 13. Hospital Pharmacies
Figure 14. Retail Pharmacies
Figure 15. Online Pharmacies
Figure 16. Others
Figure 17. Antiretroviral Agent Report Years Considered
Figure 18. Global Antiretroviral Agent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Antiretroviral Agent Revenue 2018-2029 (US$ Million)
Figure 20. Global Antiretroviral Agent Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global Antiretroviral Agent Revenue Market Share by Region (2018-2029)
Figure 22. Global Antiretroviral Agent Sales 2018-2029 ((K Units)
Figure 23. Global Antiretroviral Agent Sales Market Share by Region (2018-2029)
Figure 24. US & Canada Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 25. US & Canada Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 27. Europe Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 29. China Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 31. Asia (excluding China) Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Antiretroviral Agent Sales YoY (2018-2029) & (K Units)
Figure 33. Middle East, Africa and Latin America Antiretroviral Agent Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Antiretroviral Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of Antiretroviral Agent in the World: Market Share by Antiretroviral Agent Revenue in 2022
Figure 36. Global Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 38. Global Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 39. Global Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 40. Global Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 42. US & Canada Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 43. US & Canada Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 44. US & Canada Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada Antiretroviral Agent Revenue Share by Country (2018-2029)
Figure 46. US & Canada Antiretroviral Agent Sales Share by Country (2018-2029)
Figure 47. U.S. Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 48. Canada Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 49. Europe Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 50. Europe Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 51. Europe Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 52. Europe Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 53. Europe Antiretroviral Agent Revenue Share by Country (2018-2029)
Figure 54. Europe Antiretroviral Agent Sales Share by Country (2018-2029)
Figure 55. Germany Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 56. France Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 57. U.K. Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 58. Italy Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 59. Russia Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 60. China Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 61. China Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 62. China Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 63. China Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 64. Asia Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 65. Asia Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 66. Asia Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 67. Asia Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 68. Asia Antiretroviral Agent Revenue Share by Region (2018-2029)
Figure 69. Asia Antiretroviral Agent Sales Share by Region (2018-2029)
Figure 70. Japan Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 71. South Korea Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 72. China Taiwan Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 73. Southeast Asia Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 74. India Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 75. Middle East, Africa and Latin America Antiretroviral Agent Sales Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Antiretroviral Agent Revenue Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Antiretroviral Agent Sales Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Antiretroviral Agent Revenue Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Antiretroviral Agent Revenue Share by Country (2018-2029)
Figure 80. Middle East, Africa and Latin America Antiretroviral Agent Sales Share by Country (2018-2029)
Figure 81. Brazil Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 82. Mexico Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 83. Turkey Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 84. Israel Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 85. GCC Countries Antiretroviral Agent Revenue (2018-2029) & (US$ Million)
Figure 86. Antiretroviral Agent Value Chain
Figure 87. Antiretroviral Agent Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries